Stay updated on EPX-100 Add-on Control in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page.

Latest updates to the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.6.4 was added and Revision: v3.6.3 removed from the Record History, reflecting a small UI release update to the page rather than a change to study data.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedA new version entry on 2026-06-30 adds core study sections (Contacts/Locations, Eligibility, Arms and Interventions, Study Status) to the record, reflecting substantive updates to the trial record; the earlier revision entry (v3.6.2) from 2026-05-14 is removed.SummaryDifference0.5%

- Check37 days agoChange DetectedThe page history now shows a new frontend release (Revision: v3.6.2) added and the previous release (Revision: v3.6.0) removed, indicating a new build of the Record History page.SummaryDifference0.1%

- Check51 days agoChange DetectedThe history page now includes a new 'Check who can join' link and a 'Find Contact Information' option, and the site revision label updates from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check58 days agoChange DetectedThe page history gains a new revision entry, Revision: v3.5.5, indicating a newer update to the page. The previous revision entry, Revision: v3.5.4, is removed from the history.SummaryDifference0.1%

- Check80 days agoChange DetectedA new version adds Contacts/Locations, Study Description, and Study Status details. It also notes a new revision (v3.5.4) on 2026-05-14, reflecting updated study information and current status.SummaryDifference0.4%

Stay in the know with updates to EPX-100 Add-on Control in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page.